Murphy Capital Management’s Biogen BIIB Stock Holding History

Murphy Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-900	Closed	-$270K	–	249
2018 Q4	$270K	Hold	900	–	–	0.05%	206
2018 Q3	$317K	Sell	900 -325	-27%	-$112K	0.04%	216
2018 Q2	$355K	Buy	+1,225	New	+$344K	0.05%	206
2017 Q1	–	Sell	-925	Closed	-$262K	–	271
2016 Q4	$262K	Sell	925 -125	-12%	-$37.1K	0.04%	240
2016 Q3	$328K	Buy	+1,050	New	+$311K	0.05%	224
2016 Q2	–	Sell	-1,075	Closed	-$279K	–	303
2016 Q1	$279K	Buy	1,075 +175	+19%	+$46.2K	0.04%	245
2015 Q4	$275K	Sell	900 -1,050	-54%	-$302K	0.04%	259
2015 Q3	$569K	Buy	1,950 +950	+95%	+$314K	0.09%	174
2015 Q2	$403K	Hold	1,000	–	–	0.06%	225
2015 Q1	$422K	Hold	1,000	–	–	0.06%	230
2014 Q4	$339K	Sell	1,000 -650	-39%	-$210K	0.05%	257
2014 Q3	$545K	Sell	1,650 -100	-6%	-$33K	0.08%	198
2014 Q2	$551K	Buy	1,750 +1,000	+133%	+$301K	0.09%	199
2014 Q1	$229K	Hold	750	–	–	0.04%	302
2013 Q4	$209K	Buy	+750	New	+$194K	0.04%	301

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Murphy Capital Management's BIIB Position: Q1 2019 in Review

Murphy Capital Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 900 shares — an estimated $270K sold.

Murphy Capital Management first reported a position in BIIB in Q4 2013 and held it in 15 quarters. The position peaked at $569K in Q3 2015. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Murphy Capital Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Murphy Capital Management sold 900 Biogen shares in Q1 2019, an estimated $270K.
Murphy Capital Management first reported a position in Biogen in Q4 2013 and held it in 15 quarters.
Murphy Capital Management's Biogen position peaked at $569K in Q3 2015.
1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Murphy Capital Management's 13F filing for Q1 2019, filed 11 Apr 2019.